Cost associated with a relapse-free patient in multiple sclerosis: A real-world health indicator.

Por Lucía Romero-Pinel, Laura Bau, Elisabet Matas, Isabel León, Roser Juvany, Ramon Jódar, Antonio Martínez-Yélamos, Sergio Martínez-Yélamos
Publicado em 2022-01-01

Evaluation of Humoral and Cellular Immune Responses to the SARS-CoV-2 Vaccine in Patients With Common Variable Immunodeficiency Phenotype and Patient Receiving B-Cell Depletion The...

Por Arnau Antolí, Arnau Antolí, Arnau Antolí, Gemma Rocamora-Blanch, Gemma Rocamora-Blanch, Gemma Rocamora-Blanch, Mario Framil, Mario Framil, Mario Framil, Virgínia Mas-Bosch, Virgínia Mas-Bosch, Virgínia Mas-Bosch, Sergio Navarro, Sergio Navarro, Sergio Navarro, Carla Bermudez, Carla Bermudez, Sergio Martinez-Yelamos, Sergio Martinez-Yelamos, Sergio Martinez-Yelamos, Eva Dopico, Eva Dopico, Laura Calatayud, Laura Calatayud, Laura Calatayud, Nadia Garcia-Muñoz, Luis Humberto Hernández-Benítez, Antoni Riera-Mestre, Antoni Riera-Mestre, Antoni Riera-Mestre, Jordi Bas, Jordi Bas, Jordi Bas, Cristina Masuet-Aumatell, Cristina Masuet-Aumatell, Cristina Masuet-Aumatell, Raúl Rigo-Bonnin, Raúl Rigo-Bonnin, Francisco Morandeira, Francisco Morandeira, Francisco Morandeira, Xavier Solanich, Xavier Solanich, Xavier Solanich
Publicado em 2022-04-01

Increased C-X-C Motif Chemokine Ligand 12 Levels in Cerebrospinal Fluid as a Candidate Biomarker in Sporadic Amyotrophic Lateral Sclerosis

Por Pol Andrés-Benito, Mònica Povedano, Raúl Domínguez, Carla Marco, Maria J. Colomina, Óscar López-Pérez, Isabel Santana, Inês Baldeiras, Sergio Martínez-Yelámos, Inga Zerr, Franc Llorens, Joaquín Fernández-Irigoyen, Enrique Santamaría, Isidro Ferrer
Publicado em 2020-11-01